...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trading

As far as the bolding goes, tada may be a better person to confirm that statement about the name change.

I did not own any Zenith Shares stemming from SPINCO 2013. But have been buying ZHCLF for a while now.

 

Koo

Share
New Message
Please login to post a reply